Latest info

Cyton and Triveritas become knoell

As of February 2021, Cyton and Triveritas will become knoell which creates one animal health team based in the US, EU, China, and the UK.
company news

We are pleased to announce that knoell is bringing all of its Animal Health CRO expertise and service brands under one name to provide a unified face to customers around the world. As of February 2021, Cyton and Triveritas will become knoell which creates one animal health team based in the US, EU, China, and the UK having an industry-leading combined service expertise of over 750 years.
 

The knoell group is a family business employing almost 600 experts in 23 locations in 15 countries globally. This means easy access and broad reach for its animal health customers with knoell offices also in Brazil, France, Germany, Italy, Japan, Netherlands, Portugal, Spain, Switzerland, South Korea, Taiwan, and Thailand.

Felix Knoell, spoke for the knoell Board,

“With the expansion of knoell’s Animal Health services in the US, the recent acquisition of Triveritas, the renowned Cyton brand, and our experienced services in China – we’re delighted to create an expert one-stop shop. We believe the knoell concept of ‘Think globally, Act locally’ should provide great benefits to our animal health customers.”

knoell is the only knowledge-based animal health consultancy and clinical studies specialist with its own technical staff based on three continents: North America, Europe, and Asia. This benefits its customers by avoiding duplication, providing a better return on investment for valuable data, improving control of expenditure, and reducing administration.

Helen Edwards, joint Managing Director of the knoell business in animal health, remarked,

“We’ve already delivered thousands of projects on six continents for customers based in 26 countries worldwide. By merging our expertise, we ensure our global service is now at an even higher level, with knoell providing full-service solutions in regulatory affairs, CMC, clinical studies, safety, pre-clinical, project management, quality assurance and compliance, pharmacovigilance, training, and our start-to-finish product development service.”

Helen’s joint Managing Director, Karolina Bate, added,

“Despite the challenges of the pandemic, we are proud to have created an even better service for our customers in 2021. We will continue to provide tailor-made solutions for the smallest to the largest of animal health projects. Our in-house knoell expert team works with multiple regulatory agencies including USDA-CVB, FDA-CVM, EMA, EFSA, European national agencies, the Chinese MoA, and many others. It’s easy for our customers to have knoell as a single friendly partner with development and regulatory expertise in all product classes in animal health, including novel technologies and generics.”

WATCH NOW: To learn more about our animal health service portfolio, watch our brand new  animal health solutions video!

More News on
Animal Health